Hui Wang Selected Research

Liver Neoplasms (Liver Cancer)

1/2024	Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
1/2024	Blocking the E2F transcription factor 1/high-mobility group box 2 pathway enhances the intervention effects of α-santalol on the malignant behaviors of liver cancer cells.
1/2024	Lycorine inhibits migration and proliferation of hepatocellular carcinoma cells by reducing transketonase expression.
1/2023	Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer.
1/2023	The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB.
1/2022	Polyisocyanide hydrogels with tunable nonlinear elasticity mediate liver carcinoma cell functional response.
1/2022	A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer.
10/2021	Publisher Correction: Environmental eustress modulates β-ARs/CCL2 axis to induce anti-tumor immunity and sensitize immunotherapy against liver cancer in mice.
10/2021	Characterization of genomic clones by targeted deep sequencing of ctDNA to monitor liver cancer.
8/2021	Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Wang Research Topics

Disease

1136	Neoplasms (Cancer) 05/2024 - 01/2002
315	Infections 05/2024 - 11/2002
194	Inflammation (Inflammations) 05/2024 - 03/2005
193	Neoplasm Metastasis (Metastasis) 05/2024 - 03/2004
157	Breast Neoplasms (Breast Cancer) 05/2024 - 05/2002
105	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 04/2003
102	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 03/2003
100	Fibrosis (Cirrhosis) 04/2024 - 05/2004
98	COVID-19 04/2024 - 01/2020
86	Lung Neoplasms (Lung Cancer) 01/2024 - 02/2002
84	Carcinogenesis 01/2024 - 05/2002
83	Body Weight (Weight, Body) 03/2024 - 05/2004
80	Hypoxia (Hypoxemia) 01/2024 - 09/2003
68	Type 2 Diabetes Mellitus (MODY) 03/2024 - 11/2007
66	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 06/2006
58	Wounds and Injuries (Trauma) 05/2024 - 08/2004
58	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 09/2005
58	Hypertension (High Blood Pressure) 03/2024 - 06/2003
58	Insulin Resistance 01/2024 - 11/2006
56	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2003
56	Obesity 02/2024 - 10/2006
55	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2003
53	Pain (Aches) 04/2024 - 02/2013
53	Stomach Neoplasms (Stomach Cancer) 01/2024 - 04/2006
51	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2024 - 11/2005
49	Sepsis (Septicemia) 01/2024 - 01/2006
48	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 02/2007
45	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 11/2010
45	Carcinoma (Carcinomatosis) 03/2024 - 09/2003
42	Osteoarthritis 03/2024 - 09/2009
42	Necrosis 01/2024 - 10/2003
42	Glioma (Gliomas) 12/2023 - 03/2004
41	Nasopharyngeal Carcinoma 04/2024 - 01/2012
40	Atherosclerosis 01/2024 - 08/2007
39	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 04/2007
39	Virus Diseases (Viral Diseases) 01/2024 - 12/2009
38	Hemorrhage 04/2024 - 03/2007
38	Ischemia 12/2023 - 09/2003
38	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 09/2006
37	Disease Progression 03/2024 - 05/2013
37	Pneumonia (Pneumonitis) 03/2024 - 01/2006
36	Myocardial Infarction 01/2024 - 01/2007
35	Reperfusion Injury 03/2024 - 10/2003
35	Chronic Hepatitis B 12/2023 - 11/2003
35	Leukemia 07/2023 - 03/2004
34	Non-alcoholic Fatty Liver Disease 04/2024 - 08/2010
33	Hypersensitivity (Allergy) 04/2024 - 03/2003
33	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 02/2006
32	Lymphatic Metastasis 04/2024 - 05/2006
31	Adenocarcinoma 03/2024 - 05/2003
31	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2011
31	Cognitive Dysfunction 01/2024 - 11/2008
30	Rectal Neoplasms (Rectal Cancer) 05/2024 - 03/2007
30	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024 - 03/2006

Drug/Important Bio-Agent (IBA)

443	Proteins (Proteins, Gene)FDA Link 05/2024 - 05/2002
223	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2004
137	Messenger RNA (mRNA)IBA 03/2024 - 05/2002
118	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 08/2007
116	CytokinesIBA 05/2024 - 11/2005
108	MicroRNAs (MicroRNA)IBA 04/2024 - 08/2009
104	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 05/2002
92	LipidsIBA 03/2024 - 01/2006
82	EnzymesIBA 04/2024 - 12/2003
82	Therapeutic UsesIBA 02/2024 - 04/2002
79	RNA (Ribonucleic Acid)IBA 05/2024 - 07/2004
79	Long Noncoding RNAIBA 04/2024 - 01/2016
73	VaccinesIBA 05/2024 - 03/2003
70	AntigensIBA 04/2024 - 04/2002
60	Peptides (Polypeptides)IBA 05/2024 - 01/2005
57	CollagenIBA 05/2024 - 11/2004
57	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2006
56	CholesterolIBA 03/2024 - 01/2007
51	Interleukin-6 (Interleukin 6)IBA 05/2024 - 01/2003
49	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 07/2004
46	Small Interfering RNA (siRNA)IBA 04/2024 - 11/2005
46	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 03/2004
45	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 03/2012
44	LigandsIBA 11/2023 - 04/2003
43	Antiviral Agents (Antivirals)IBA 12/2023 - 07/2005
41	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2024 - 01/2004
41	Insulin (Novolin)FDA Link 01/2024 - 08/2007
39	GlucocorticoidsIBA 02/2024 - 11/2007
38	AntioxidantsIBA 01/2024 - 12/2003
36	Phosphotransferases (Kinase)IBA 01/2024 - 05/2002
36	Blood Glucose (Blood Sugar)IBA 01/2024 - 01/2011
36	Caffeine (No Doz)FDA LinkGeneric 12/2023 - 01/2012
35	InterferonsIBA 05/2024 - 04/2012
35	Indicators and Reagents (Reagents)IBA 04/2024 - 12/2004
34	Oxygen (Dioxygen)IBA 03/2024 - 01/2006
34	AntibodiesIBA 10/2023 - 05/2003
32	Transcription Factors (Transcription Factor)IBA 01/2024 - 01/2005
31	Triglycerides (Triacylglycerol)IBA 04/2024 - 08/2007

Therapy/Procedure

571	Therapeutics 05/2024 - 01/2002
162	Drug Therapy (Chemotherapy) 05/2024 - 09/2003
108	Radiotherapy 05/2024 - 12/2003
101	Immunotherapy 03/2024 - 03/2003
56	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2024 - 01/2008
37	Aftercare (After-Treatment) 01/2024 - 03/2004
35	Neoadjuvant Therapy 05/2024 - 10/2012
33	Transplantation 11/2023 - 01/2007